BRAF and adenocarcinoma: Similarly, BRAF mutations are much more common in lung premalignant lesions than in adenocarcinomas (Izumchenko et al., 2015), raising the possibility that BRAF mutations in lung epithelium could similarly reside on decoy adaptive peaks.